BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37061628)

  • 1. Trends in the incidence of urothelial carcinoma in Taiwan after the ban on aristolochic acid-containing Chinese herbal preparations, 2001-2018: a national population-based cohort study.
    Liao CI; Fang HC; Lee PT; Hsu CY; Chen CL; Huang CW; Chen XY; Ou SH; Tsai CT; Chou KJ
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):8201-8211. PubMed ID: 37061628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aristolochic acid-containing Chinese herbal medicine and upper urinary tract urothelial carcinoma in Taiwan: a narrative review.
    Dickman KG; Chen CH; Grollman AP; Pu YS
    World J Urol; 2023 Apr; 41(4):899-907. PubMed ID: 35867141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latency period of aristolochic acid-induced upper urinary tract urothelial carcinoma.
    Jhuang JR; Chiu PC; Hsieh TC; Chen CH; Pu YS; Lee WC
    Front Public Health; 2023; 11():1072864. PubMed ID: 36969664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher risk of urothelial carcinoma in the upper urinary tract than in the urinary bladder in hemodialysis patients.
    Hsiao PJ; Hsieh PF; Chang CH; Wu HC; Yang CR; Huang CP
    Ren Fail; 2016 Jun; 38(5):663-70. PubMed ID: 26956094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends and sex-specific incidence of upper urinary tract cancer in Taiwan: A birth cohort study.
    Chang YH; Hsu WL; Lee YK; Chiang CJ; Yang YW; You SL; Chen YC; Lai TS
    Cancer Med; 2023 Jul; 12(14):15350-15357. PubMed ID: 37392179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Additive Effects of Arsenic and Aristolochic Acid in Chemical Carcinogenesis of Upper Urinary Tract Urothelium.
    Chen CH; Grollman AP; Huang CY; Shun CT; Sidorenko VS; Hashimoto K; Moriya M; Turesky RJ; Yun BH; Tsai K; Wu S; Chuang PY; Tang CH; Yang WH; Tzai TS; Tsai YS; Dickman KG; Pu YS
    Cancer Epidemiol Biomarkers Prev; 2021 Feb; 30(2):317-325. PubMed ID: 33277322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased risk of urinary tract cancer in ESRD patients associated with usage of Chinese herbal products suspected of containing aristolochic acid.
    Wang SM; Lai MN; Wei A; Chen YY; Pu YS; Chen PC; Wang JD
    PLoS One; 2014; 9(8):e105218. PubMed ID: 25170766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aristolochic acid-induced upper tract urothelial carcinoma in Taiwan: clinical characteristics and outcomes.
    Chen CH; Dickman KG; Huang CY; Moriya M; Shun CT; Tai HC; Huang KH; Wang SM; Lee YJ; Grollman AP; Pu YS
    Int J Cancer; 2013 Jul; 133(1):14-20. PubMed ID: 23292929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aristolochic acid-associated urinary tract cancers: an updated meta-analysis of risk and oncologic outcomes after surgery and systematic review of molecular alterations observed in human studies.
    Kang YC; Chen MH; Lin CY; Lin CY; Chen YT
    Ther Adv Drug Saf; 2021; 12():2042098621997727. PubMed ID: 33815744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased risks of upper tract urothelial carcinoma in male and female chinese herbalists.
    Yang HY; Wang JD; Lo TC; Chen PC
    J Formos Med Assoc; 2011 Mar; 110(3):161-8. PubMed ID: 21497279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Genomic Profiling of Upper-tract and Bladder Urothelial Carcinoma.
    Necchi A; Madison R; Pal SK; Ross JS; Agarwal N; Sonpavde G; Joshi M; Yin M; Miller VA; Grivas P; Chung JH; Ali SM
    Eur Urol Focus; 2021 Nov; 7(6):1339-1346. PubMed ID: 32861617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction in the Incidence of Urological Cancers after the Ban on Chinese Herbal Products Containing Aristolochic Acid: An Interrupted Time-Series Analysis.
    Jhuang JR; Chiang CJ; Su SY; Yang YW; Lee WC
    Sci Rep; 2019 Dec; 9(1):19860. PubMed ID: 31882686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upper urinary tract urothelial carcinoma in eastern Taiwan: high proportion among all urothelial carcinomas and correlation with chronic kidney disease.
    Chen CY; Liao YM; Tsai WM; Kuo HC
    J Formos Med Assoc; 2007 Dec; 106(12):992-8. PubMed ID: 18194904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased upper and lower tract urothelial carcinoma in patients with end-stage renal disease: a nationwide cohort study in Taiwan during 1997-2008.
    Wang SM; Lai MN; Chen PC; Pu YS; Lai MK; Hwang JS; Wang JD
    Biomed Res Int; 2014; 2014():149750. PubMed ID: 25025033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of secondary primary malignancies in survivors of upper tract urothelial carcinoma: A nationwide population-based analysis.
    Wu KY; Cheong IS; Lai JN; Hu CY; Hung KC; Chen YT; Chiu LT; Tsai HT; Jou YC; Tzai TS; Tsai YS
    Cancer Epidemiol; 2024 Apr; 89():102536. PubMed ID: 38281454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aristolochic acid mutational signature defines the low-risk subtype in upper tract urothelial carcinoma.
    Lu H; Liang Y; Guan B; Shi Y; Gong Y; Li J; Kong W; Liu J; Fang D; Liu L; He Q; Shakeel M; Li X; Zhou L; Ci W
    Theranostics; 2020; 10(10):4323-4333. PubMed ID: 32292497
    [No Abstract]   [Full Text] [Related]  

  • 17. Unusual presentation of upper urinary tract urothelial carcinoma in Taiwan: Direct comparison from Taiwan-Japan UTUC Collaboration Cohort.
    Luo HL; Ohyama C; Hatakeyama S; Wang HJ; Yoneyama T; Yang WC; Chuang YC; Chen YT; Lee WC; Cheng YT; Kang CH; Chiang PH
    Int J Urol; 2020 Apr; 27(4):327-332. PubMed ID: 32100370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IGFBP-5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder.
    Liang PI; Wang YH; Wu TF; Wu WR; Liao AC; Shen KH; Hsing CH; Shiue YL; Huang HY; Hsu HP; Chen LT; Lin CY; Tai C; Wu JY; Li CF
    J Clin Pathol; 2013 Jul; 66(7):573-82. PubMed ID: 23539739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and survival variations of upper tract urothelial cancer in Taiwan (2001-2010).
    Lin MY; Niu SW; Li WM; Lee HL; Chen LT; Wu WJ; Hwang SJ
    Int J Urol; 2022 Feb; 29(2):121-127. PubMed ID: 34708447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Genomic Characterization in Upper Tract Urothelial Carcinoma and Urothelial Carcinoma of the Bladder.
    Yang K; Yu W; Liu H; Ding F; Zhang Y; Zhang Y; Wang W; Lou F; Cao S; Wang H; He Z
    Oncologist; 2021 Aug; 26(8):e1395-e1405. PubMed ID: 34050578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.